Table 4.

High-risk HPV prevalence stratified by cytology and histology results

	Total N	Home-based Self-Collection		Clinic Self-Collection		Clinician Collection
		hrHPV%*	(95%CI)	hrHPV%	(95%CI)	hrHPV%	(95%CI)
Cytology (n=193)†
Normal	178	8.4	(5.2–13.4)	12.4	(8.3–18.0)	7.3	(4.3–12.1)
ASC-US‡	6	33.3	(9.7–70.0)	16.7	(3.0–56.4)	33.3	(9.7–70.0)
LSIL§	3	66.7	(20.8–93.9)	66.7	(20.8–93.9)	66.7	(20.8–93.9)
ASC-H ||	3	66.7	(20.8–93.9)	66.7	(20.8–93.9)	66.7	(20.8–93.9)
HSIL+ ¶	3	100.0	(43.9–100.0)	100.0	(43.9–100.0)	100.0	(43.9–100.0)
Histology (n=190)#
Normal**	184	8.7	(5.4–13.7)	12.5	(8.5–18.1)	7.6	(4.6–12.4)
CIN2+††	6	100.0	(61.0–100.0)	83.3	(43.7–97.0)	100.0	(61.0–100.0)

^*hrHPV=high-risk human papillomavirus;

^†Analyses limited to participants with conclusive cytology and hrHPV results on all three sample types;

^‡ASC-US=atypical squamous cells of undetermined significance;

^§LSIL=low-grade squamous intraepithelial lesion;

^||ASC-H=atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion;

^¶HSIL+=high-grade squamous intraepithelial lesion or worse;

^#Excludes 1 ASC-US hrHPV-positive, 1 ASC-H, and 1 LSIL referred to colposcopy but lost to follow-up. No CIN1 cases were detected.

^**Includes women with normal cytology for whom colposcopy was not recommended and thus histology not conducted.

^††CIN2+=cervical intraepithelial neoplasia 2 or more severe; Histology results: 3 cases CIN2/3, 2 cases CIN3, 1 case CIN3/CIS